{"id":58569,"date":"2026-05-29T19:05:00","date_gmt":"2026-05-29T12:05:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=58569"},"modified":"2026-05-29T19:05:00","modified_gmt":"2026-05-29T12:05:00","slug":"coopervision-names-muru-annamalai-as-president-asia-pacific","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=58569","title":{"rendered":"CooperVision Names Muru Annamalai as President, Asia-Pacific"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2854596\/CooperVision_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"prntac\"><i>Experienced Global Healthcare Leader to Guide Growth Across the Region<\/i><\/p>\n<p><span class=\"legendSpanClass\">SINGAPORE<\/span>, <span class=\"legendSpanClass\">May 29, 2026<\/span> \/PRNewswire\/ &#8212; CooperVision has named Muru Annamalai as President, Asia-Pacific, effective June 1. He brings more than two decades of global leadership experience across the pharmaceutical and healthcare sectors, with extensive expertise leading commercial organizations and driving growth across Asia-Pacific, Latin America, and other global markets. His appointment reflects CooperVision&#8217;s broader investment in guiding the company&#8217;s next phase of growth across one of its most dynamic and strategically important regions.<\/p>\n<div dir=\"ltr\">   <a href=\"https:\/\/mma.prnasia.com\/media2\/2990315\/Muru_1.jpg?p=medium600\" target=\"_blank\"><img decoding=\"async\" title=\"Muru Annamalai, President, Asia-Pacific, CooperVision\" src=\"https:\/\/mma.prnasia.com\/media2\/2990315\/Muru_1.jpg?p=medium600\" alt=\"Muru Annamalai, President, Asia-Pacific, CooperVision\" align=\"middle\" \/><\/a>   <br \/>   <span>Muru Annamalai, President, Asia-Pacific, CooperVision<\/span>  <\/div>\n<p>Throughout his career, Annamalai has consistently built and led high-performing teams, expanded business operations across emerging and established markets, and delivered strong commercial results through collaborative leadership and strategic execution. He held a series of senior leadership roles with AbbVie and Abbott. Most recently, he served as a Vice President with TCA Venture Group, where he was active in the venture and investment community, supporting innovation and growth initiatives in healthcare.<\/p>\n<p>&#8220;Muru is exactly the kind of leader who can accelerate CooperVision&#8217;s growth, deepen customer partnerships, and expand access to our portfolio across Asia-Pacific,&#8221; said Debbie Olive, Chief Commercial Officer. &#8220;He brings a strong understanding of how bold thinking and disciplined commercial execution drive lasting impact. I&#8217;m confident he will build on the region&#8217;s strong foundation and further advance our leadership.&#8221;<\/p>\n<p>&#8220;I&#8217;ve always been drawn to organizations where purposeful innovation and genuine commitment to patients come together. CooperVision is exactly that, a company that advances vision care in ways that are both clinically meaningful and designed for the way people see and live. I look forward to working as part of the team bringing these solutions to more wearers across the region,&#8221; said Annamalai.<\/p>\n<p>Annamalai holds a bachelor&#8217;s degree in mathematics from the University Malaya and a master&#8217;s in business administration from Heriot-Watt University in the United Kingdom. Originally from Malaysia, he brings a global perspective shaped by decades of personal and professional experience around the world.<\/p>\n<p><b><u>About CooperVision<br \/><\/u><\/b>CooperVision, a division of CooperCompanies\u00a0(Nasdaq:COO), is one of the world&#8217;s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology\u00a0and scleral\u00a0designs. CooperVision\u00a0has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric, and multifocal\u00a0products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4699358-1&amp;h=3551812635&amp;u=http%3A%2F%2Fwww.coopervision.com%2F&amp;a=www.coopervision.com\" target=\"_blank\" rel=\"nofollow\">www.coopervision.com<\/a>.<\/p>\n<p><b><u>About CooperCompanies<br \/><\/u><\/b>CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life&#8217;s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women&#8217;s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4699358-1&amp;h=763920883&amp;u=https%3A%2F%2Fwww.coopercos.com%2F&amp;a=www.coopercos.com\" target=\"_blank\" rel=\"nofollow\">www.coopercos.com<\/a>.<\/p>\n<p><b>Media Contact<br \/><\/b>Shannon Morrow<br \/>M: +61 437 866918<br \/>E: <a href=\"mailto:smorrow@au.coopervision.com\" target=\"_blank\" rel=\"nofollow\">smorrow@au.coopervision.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2854596\/CooperVision_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"prntac\"><i>Experienced Global Healthcare Leader to Guide Growth Across the Region<\/i><\/p>\n<p><span class=\"legendSpanClass\">SINGAPORE<\/span>, <span class=\"legendSpanClass\">May 29, 2026<\/span> \/PRNewswire\/ &#8212; CooperVision has named Muru Annamalai as President, Asia-Pacific, effective June 1. He brings more than two decades of global leadership experience across the pharmaceutical and healthcare sectors, with extensive expertise leading commercial organizations and driving growth across Asia-Pacific, Latin America, and other global markets. His appointment reflects CooperVision&#8217;s broader investment in guiding the company&#8217;s next phase of growth across one of its most dynamic and strategically important regions.<\/p>\n<div dir=\"ltr\">   <a href=\"https:\/\/mma.prnasia.com\/media2\/2990315\/Muru_1.jpg?p=medium600\" target=\"_blank\"><img decoding=\"async\" title=\"Muru Annamalai, President, Asia-Pacific, CooperVision\" src=\"https:\/\/mma.prnasia.com\/media2\/2990315\/Muru_1.jpg?p=medium600\" alt=\"Muru Annamalai, President, Asia-Pacific, CooperVision\" align=\"middle\" \/><\/a>   <br \/>   <span>Muru Annamalai, President, Asia-Pacific, CooperVision<\/span>  <\/div>\n<p>Throughout his career, Annamalai has consistently built and led high-performing teams, expanded business operations across emerging and established markets, and delivered strong commercial results through collaborative leadership and strategic execution. He held a series of senior leadership roles with AbbVie and Abbott. Most recently, he served as a Vice President with TCA Venture Group, where he was active in the venture and investment community, supporting innovation and growth initiatives in healthcare.<\/p>\n<p>&#8220;Muru is exactly the kind of leader who can accelerate CooperVision&#8217;s growth, deepen customer partnerships, and expand access to our portfolio across Asia-Pacific,&#8221; said Debbie Olive, Chief Commercial Officer. &#8220;He brings a strong understanding of how bold thinking and disciplined commercial execution drive lasting impact. I&#8217;m confident he will build on the region&#8217;s strong foundation and further advance our leadership.&#8221;<\/p>\n<p>&#8220;I&#8217;ve always been drawn to organizations where purposeful innovation and genuine commitment to patients come together. CooperVision is exactly that, a company that advances vision care in ways that are both clinically meaningful and designed for the way people see and live. I look forward to working as part of the team bringing these solutions to more wearers across the region,&#8221; said Annamalai.<\/p>\n<p>Annamalai holds a bachelor&#8217;s degree in mathematics from the University Malaya and a master&#8217;s in business administration from Heriot-Watt University in the United Kingdom. Originally from Malaysia, he brings a global perspective shaped by decades of personal and professional experience around the world.<\/p>\n<p><b><u>About CooperVision<br \/><\/u><\/b>CooperVision, a division of CooperCompanies\u00a0(Nasdaq:COO), is one of the world&#8217;s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology\u00a0and scleral\u00a0designs. CooperVision\u00a0has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric, and multifocal\u00a0products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4699358-1&amp;h=3551812635&amp;u=http%3A%2F%2Fwww.coopervision.com%2F&amp;a=www.coopervision.com\" target=\"_blank\" rel=\"nofollow\">www.coopervision.com<\/a>.<\/p>\n<p><b><u>About CooperCompanies<br \/><\/u><\/b>CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life&#8217;s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women&#8217;s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4699358-1&amp;h=763920883&amp;u=https%3A%2F%2Fwww.coopercos.com%2F&amp;a=www.coopercos.com\" target=\"_blank\" rel=\"nofollow\">www.coopercos.com<\/a>.<\/p>\n<p><b>Media Contact<br \/><\/b>Shannon Morrow<br \/>M: +61 437 866918<br \/>E: <a href=\"mailto:smorrow@au.coopervision.com\" target=\"_blank\" rel=\"nofollow\">smorrow@au.coopervision.com<\/a><\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-58569","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/58569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58569"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/58569\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=58569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=58569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}